Largest Measles Epidemic in North America in a Decade--Quebec, Canada, 2011: Contribution of Susceptibility, Serendipity, and Superspreading Events

Institut national de santé publique du Québec, Quebec, Canada.
The Journal of Infectious Diseases (Impact Factor: 6). 12/2012; 207(6). DOI: 10.1093/infdis/jis923
Source: PubMed


The largest measles epidemic in North America in the last decade, occurred in 2011 in Quebec, Canada, where rates of 1- and 2-dose vaccine coverage among children 3 years of age were 95%-97% and 90%, respectively, with 3%-5% unvaccinated.

Case patients identified through passive surveillance and outbreak investigation were contacted to determine clinical course, vaccination status, and possible source of infection.

There were 21 measles importations and 725 cases. A superspreading event triggered by 1 importation resulted in sustained transmission and 678 cases. The overall incidence was 9.1 per 100,000; the highest incidence was in adolescents 12-17 years old (75.6 per 100,000), who comprised 56% of case patients. Among adolescents, 22% had received 2 vaccine doses. Outbreak investigation showed this proportion to have been an underestimate; active case finding identified 130% more cases among 2-dose recipients. Two-dose recipients had milder illness and a significantly lower risk of hospitalization than those who were unvaccinated or single-dose recipients.

A chance superspreading event revealed an overall level of immunity barely above the elimination threshold when unexpected vulnerability in 2-dose recipients was taken into account. Unvaccinated individuals remain the immunization priority, but a better understanding of susceptibility in 2-dose recipients is needed to define effective interventions if elimination is to be achieved.

19 Reads
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Cochrane Review: Vaccines for measles, mumps and rubella in children Demicheli V, Rivetti A, Debalini MG, Di Pietrantonj C. Vaccines for measles, mumps and rubella in children. Cochrane Database of Systematic Reviews 2012, Issue 2. Art. No.: CD004407. DOI: 10.1002/14651858.CD004407.pub3 This companion piece to the review, "Vaccines for measles, mumps and rubella in children," contains the following pieces: The abstract of the review A commentary from one or more of the review authors, explaining why the review team felt the review was an important one to produce A commentary from Joan Robinson, Editor-in-chief, outlining the review's findings A review of clinical practice guidelines from the American Academy of Pediatrics, the Canadian Paediatric Society and the National Institute for Health and Care Excellence (NICE), United Kingdom Some other recently published references on this topic Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd..
    Cochrane database of systematic reviews (Online) 02/2012; 2(2):CD004407. DOI:10.1002/14651858.CD004407.pub3 · 6.03 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Despite being recognized as one of the most successful public health measures, vaccination is perceived as unsafe and unnecessary by a growing number of individuals. Lack of confidence in vaccines is now considered a threat to the success of vaccination programs. Vaccine hesitancy is believed to be responsible for decreasing vaccine coverage and an increasing risk of vaccine-preventable disease outbreaks and epidemics. This review provides an overview of the phenomenon of vaccine hesitancy. First, we will characterize vaccine hesitancy and suggest the possible causes of the apparent increase in vaccine hesitancy in the developed world. Then we will look at determinants of individual decision-making about vaccination.
    Human Vaccines & Immunotherapeutics 04/2013; 9(8). DOI:10.4161/hv.24657 · 2.37 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Parental vaccine hesitancy is a growing problem affecting the health of children and the larger population. This article describes the evolution of the vaccine hesitancy movement and the individual, vaccine-specific and societal factors contributing to this phenomenon. In addition, potential strategies to mitigate the rising tide of parent vaccine reluctance and refusal are discussed.
    Human Vaccines & Immunotherapeutics 06/2013; 9(8). DOI:10.4161/hv.25085 · 2.37 Impact Factor
Show more